• Bio-Works posted Q2 net sales of SEK 20 million, up 53% year over year.
• Operating loss narrowed to SEK 3.1 million; loss for the quarter improved to SEK 2.5 million, EPS was SEK -0.02.
• Order intake fell to SEK 8.9 million; management cited post-period orders of about SEK 31.5 million from recurring customers.
• Operating cash flow was SEK -10.9 million; cash and cash equivalents ended the period at SEK 30 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio-Works Technologies AB published the original content used to generate this news brief via Cision (Ref. ID: 20260819:BIT:9613:0) on August 21, 2026, and is solely responsible for the information contained therein.